Singapore-Sichuan Hi-Tech Innovation Park (SSCIP) conducted its 2nd investment promotion trip to the United States, from 9 – 18 September 2014.
On 13 September, SSCIP attended Sino-American Pharmaceutical Professionals Association (SAPA)’s 22nd Annual Conference at Princeton University, the theme being “Shaping the Medicine of Tomorrow”. Vice President of Sembcorp Development and Representative of SSCIP, Mr. Chong Joon Woon, gave a speech during the annual dinner entitled “Harnessing the Biomedical Potential in West China”, presenting the Park’s competitive edge and Chengdu’s attractive biomedical resources. SSCIP was granted the “SAPA Corporate Excellence Award” in recognition of the outstanding contribution to SAPA.
▲Vice President of Sembcorp Development & Representative of SSCIP, Mr. Chong Joon Woon, receiving “SAPA Corporate Excellence Award” from SAPA President Dr. Yan Ning at Princeton University
During the trip, SSCIP was invited to meet 11 influential companies and organizations, including mega pharmaceutical enterprises like Bristol-Meyer Squibb, Sanofi, Novartis, and leading CROs like Fountain Medical and Frontage.
SSCIP not only obtained first-hand information regarding the biomedical industry’s developmental trends, but uncovered numerous investment opportunities.
About Sino-American Pharmaceutical Professionals Association (SAPA)
Sino-American Pharmaceutical Professionals Association (SAPA) was founded in 1993 and grew rapidly to become one of the most active and well-recognized professional organizations in the United States. SAPA is an independent, nonprofit organization with a membership base of over 3000 in more than 35 states in the United States, China Mainland, Hong Kong, Taiwan and Japan.
For more information, please visit http://www.sapaweb.org/new/index.htm
